文献速递泌尿生殖腹部MR

多参数MRI人工智能衍生肿瘤体积与局限性前列腺癌结局

AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
PubMed 文献 · Radiology · 2024-01-01

回顾性单中心研究纳入732例接受放疗或根治性前列腺切除术的局限性前列腺癌患者,基于多参数MRI训练人工智能分割算法勾画PI-RADS 3-5病灶并计算肿瘤总体积(VAI)。VAI与转移风险独立相关,联合放疗组7年转移AUC高于NCCN风险分类,根治术组5年AUC差异未达统计学显著。

要点

  • VAI每增加1 mL,联合放疗组转移风险AHR 1.09,根治术组AHR 1.22。
  • 联合放疗组7年转移AUC:VAI 0.84 vs NCCN风险分类0.74,P=.02。
  • 根治术组5年转移AUC:VAI 0.89 vs NCCN风险分类0.79,P=.25。

核心结论

  • 基于人工智能分割的病灶体积是局限性前列腺癌的独立预后因素。

研究设计与样本

  • 回顾性单中心研究,时间范围为2021年1月至2023年8月。
  • 共纳入732例cT1-3N0M0前列腺癌患者,均接受MRI检查并接受放疗或根治性前列腺切除术。
  • 联合放疗组438例,根治术组294例;放疗组随机分为交叉验证组和测试组。
  • 人工智能分割算法在交叉验证放疗组中训练以勾画PI-RADS 3-5病灶,再用于测试放疗组和根治术组。
  • 采用Cox回归评估VAI与转移时间的关联,并校正临床和影像因素;计算VAI与NCCN风险分类预测转移的AUC。

诊断标准与关键数值

  • 联合放疗组中位随访6.9年,VAI与转移相关,每增加1 mL的校正风险比AHR为1.09(95%CI 1.04-1.15,P=.001)。
  • 根治术组中位随访5.5年,VAI与转移相关,AHR为1.22(95%CI 1.08-1.39,P=.001)。
  • 联合放疗组7年转移AUC:VAI为0.84(95%CI 0.74-0.94),NCCN风险分类为0.74(95%CI 0.80-0.98),P=.02。
  • 根治术组5年转移AUC:VAI为0.89(95%CI 0.80-0.98),NCCN风险分类为0.79(95%CI 0.64-0.94),P=.25。

临床应用与阅片要点

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background An artificial intelligence (AI)-based method for measuring intraprostatic tumor volume based on data from MRI may provide prognostic information. Purpose To evaluate whether the total volume of intraprostatic tumor from AI-generated segmentations (VAI) provides independent prognostic information in patients with localized prostate cancer treated with radiation therapy (RT) or radical prostatectomy (RP). Materials and Methods For this retrospective, single-center study (January 2021 to August 2023), patients with cT1-3N0M0 prostate cancer who underwent MRI and were treated with RT or RP were identified. Patients who underwent RT were randomly divided into cross-validation and test RT groups. An AI segmentation algorithm was trained to delineate Prostate Imaging Reporting and Data System (PI-RADS) 3-5 lesions in the cross-validation RT group before providing segmentations for the test RT and RP groups. Cox regression models were used to evaluate the association between VAI and time to metastasis and adjusted for clinical and radiologic factors for combined RT (ie, cross-validation RT and test RT) and RP groups. Areas under the receiver operating characteristic curve (AUCs) were calculated for VAI and National Comprehensive Cancer Network (NCCN) risk categorization for prediction of 5-year metastasis (RP group) and 7-year metastasis (combined RT group). Results Overall, 732 patients were included (combined RT group, 438 patients; RP group, 294 patients). Median ages were 68 years (IQR, 62-73 years) and 61 years (IQR, 56-66 years) for the combined RT group and the RP group, respectively. VAI was associated with metastasis in the combined RT group (median follow-up, 6.9 years; adjusted hazard ratio [AHR], 1.09 per milliliter increase; 95% CI: 1.04, 1.15; P = .001) and the RP group (median follow-up, 5.5 years; AHR, 1.22; 95% CI: 1.08, 1.39; P = .001). AUCs for 7-year metastasis for the combined RT group for VAI and NCCN risk category were 0.84 (95% CI: 0.74, 0.94) and 0.74 (95% CI: 0.80, 0.98), respectively (P = .02). Five-year AUCs for the RP group for VAI and NCCN risk category were 0.89 (95% CI: 0.80, 0.98) and 0.79 (95% CI: 0.64, 0.94), respectively (P = .25). Conclusion The volume of AI-segmented lesions was an independent, prognostic factor for localized prostate cancer. © RSNA, 2024 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yang DD, Lee LK, Tsui JMG, et al. AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer. Radiology. 2024. PMID: 39470422. doi:10.1148/radiol.240041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。